Bluejay Diagnostics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $216 | $216 |
Gross Profit | -38 | -51 | 108 | |
EBITDA | -1,586 | -1,918 | -1,837 | -1,393 |
EBIT | -1,597 | -1,956 | -1,888 | -1,431 |
Net Income | -1,597 | -1,956 | -1,864 | -1,431 |
Net Change In Cash | 0 | 0 | 216 | 216 |
Free Cash Flow | -1,359 | -2,054 | -1,184 | -1,739 |
Cash | 3,082 | 4,443 | 3,116 | 4,301 |
Basic Shares | 1,574 | 1,387 | 160 | 160 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $249 | $ |
Gross Profit | -199 | -780 | 48 | -145 |
EBITDA | -6,695 | -9,172 | -9,011 | -3,084 |
EBIT | -6,894 | -9,953 | -9,317 | -3,230 |
Net Income | -7,717 | -9,953 | -9,296 | -3,729 |
Net Change In Cash | 0 | 0 | 249 | |
Free Cash Flow | -8,126 | -9,018 | -8,940 | -4,390 |
Cash | 4,301 | 2,208 | 10,114 | 19,047 |
Basic Shares | 183 | 137 | 126 | 125 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.01 |
2025-06-30 | -$1.41 |
2025-03-31 | -$3.37 |
2024-12-31 | -$27.81 |
